- Home
- TIPT vs QURE Comparison
TIPT vs QURE Comparison
Compare TIPT & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIPT
- QURE
- Stock Information
- Founded
- TIPT 2007
- QURE 1998
- Country
- TIPT United States
- QURE Netherlands
- Employees
- TIPT N/A
- QURE N/A
- Industry
- TIPT Property-Casualty Insurers
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- TIPT Finance
- QURE Health Care
- Exchange
- TIPT Nasdaq
- QURE Nasdaq
- Market Cap
- TIPT 808.7M
- QURE 725.4M
- IPO Year
- TIPT 2007
- QURE 2007
- Fundamental
- Price
- TIPT $22.87
- QURE $14.49
- Analyst Decision
- TIPT
- QURE Strong Buy
- Analyst Count
- TIPT 0
- QURE 10
- Target Price
- TIPT N/A
- QURE $37.20
- AVG Volume (30 Days)
- TIPT 126.4K
- QURE 2.1M
- Earning Date
- TIPT 04-30-2025
- QURE 05-09-2025
- Dividend Yield
- TIPT 1.05%
- QURE N/A
- EPS Growth
- TIPT 107.58
- QURE N/A
- EPS
- TIPT 1.20
- QURE N/A
- Revenue
- TIPT $2,042,059,000.00
- QURE $20,201,000.00
- Revenue This Year
- TIPT N/A
- QURE $60.54
- Revenue Next Year
- TIPT N/A
- QURE $183.28
- P/E Ratio
- TIPT $18.42
- QURE N/A
- Revenue Growth
- TIPT 15.66
- QURE 6.30
- 52 Week Low
- TIPT $15.60
- QURE $3.73
- 52 Week High
- TIPT $26.90
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- TIPT 48.38
- QURE 53.84
- Support Level
- TIPT $21.30
- QURE $14.06
- Resistance Level
- TIPT $22.40
- QURE $16.20
- Average True Range (ATR)
- TIPT 0.50
- QURE 0.95
- MACD
- TIPT 0.06
- QURE -0.02
- Stochastic Oscillator
- TIPT 44.26
- QURE 54.02
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.